9-136544100-G-A

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_017617.5(NOTCH1):​c.64C>T​(p.Pro22Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0012 in 1,571,134 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00074 ( 5 hom. )

Consequence

NOTCH1
NM_017617.5 missense, splice_region

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: 1.59
Variant links:
Genes affected
NOTCH1 (HGNC:7881): (notch receptor 1) This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), NOTCH1. . Trascript score misZ 3.6761 (greater than threshold 3.09). GenCC has associacion of gene with familial bicuspid aortic valve, familial thoracic aortic aneurysm and aortic dissection, Adams-Oliver syndrome, connective tissue disorder, Adams-Oliver syndrome 5, aortic valve disease 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.0060311854).
BP6
Variant 9-136544100-G-A is Benign according to our data. Variant chr9-136544100-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 134923.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-136544100-G-A is described in Lovd as [Benign]. Variant chr9-136544100-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00553 (842/152326) while in subpopulation AFR AF= 0.0178 (738/41564). AF 95% confidence interval is 0.0167. There are 2 homozygotes in gnomad4. There are 436 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 842 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NOTCH1NM_017617.5 linkuse as main transcriptc.64C>T p.Pro22Ser missense_variant, splice_region_variant 2/34 ENST00000651671.1 NP_060087.3 P46531
NOTCH1XM_011518717.3 linkuse as main transcriptc.-58C>T upstream_gene_variant XP_011517019.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NOTCH1ENST00000651671.1 linkuse as main transcriptc.64C>T p.Pro22Ser missense_variant, splice_region_variant 2/34 NM_017617.5 ENSP00000498587.1 P46531

Frequencies

GnomAD3 genomes
AF:
0.00550
AC:
837
AN:
152208
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0177
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.00164
AC:
298
AN:
181272
Hom.:
1
AF XY:
0.00137
AC XY:
133
AN XY:
97430
show subpopulations
Gnomad AFR exome
AF:
0.0190
Gnomad AMR exome
AF:
0.00211
Gnomad ASJ exome
AF:
0.000451
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000123
Gnomad FIN exome
AF:
0.000183
Gnomad NFE exome
AF:
0.000448
Gnomad OTH exome
AF:
0.00125
GnomAD4 exome
AF:
0.000736
AC:
1044
AN:
1418808
Hom.:
5
Cov.:
31
AF XY:
0.000697
AC XY:
489
AN XY:
701926
show subpopulations
Gnomad4 AFR exome
AF:
0.0159
Gnomad4 AMR exome
AF:
0.00235
Gnomad4 ASJ exome
AF:
0.000550
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000866
Gnomad4 FIN exome
AF:
0.0000808
Gnomad4 NFE exome
AF:
0.000272
Gnomad4 OTH exome
AF:
0.00167
GnomAD4 genome
AF:
0.00553
AC:
842
AN:
152326
Hom.:
2
Cov.:
33
AF XY:
0.00585
AC XY:
436
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.0178
Gnomad4 AMR
AF:
0.00333
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000529
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00259
Hom.:
4
Bravo
AF:
0.00623
ESP6500AA
AF:
0.0115
AC:
48
ESP6500EA
AF:
0.000238
AC:
2
ExAC
AF:
0.00142
AC:
167
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
not specified Benign:3Other:1
not provided, no classification providedreference populationITMISep 19, 2013- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 15, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 21, 2023- -
Familial thoracic aortic aneurysm and aortic dissection Benign:2
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 07, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioNov 30, 2016- -
Adams-Oliver syndrome 5 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 26, 2024- -
NOTCH1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 17, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Aortic valve disease 1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
19
DANN
Benign
0.87
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.50
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.20
N
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
0.16
N
REVEL
Benign
0.11
Sift
Benign
0.073
T
Sift4G
Benign
0.43
T
Polyphen
0.046
B
Vest4
0.14
MVP
0.54
MPC
0.39
ClinPred
0.0038
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.031

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114832250; hg19: chr9-139438552; COSMIC: COSV53038631; COSMIC: COSV53038631; API